Clinical Trial Update: A Study on the Safety and Tolerability of Universal STAR-T Cell Therapy for Multiple Sclerosis. [Phase 1]

View source ↗

Summary

Phase 1 clinical trial updating safety and tolerability data for Universal STAR-T Cell Therapy in multiple sclerosis; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Universal STAR-T Cell Therapy

Snippet

Sponsor: Daishi Tian | Conditions: Multiple Sclerosis (MS) | Phase 1 | Status: NOT_YET_RECRUITING